To Be Discontinued Tablet Cardiovascular

Midodrine Hydrochloride Tabl · 501 days since initial FDA posting

Compiled by PlainMeds, Drug Information Editorial Process

Brand: MIDODRINE HYDROCHLORIDE

FDA lists Midodrine Hydrochloride Tabl as To Be Discontinued (Upsher-Smith Laboratories, LLC).

No availability text on this FDA row.

Midodrine Hydrochloride Tablet: To Be Discontinued

FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.

Shortage Details

Generic Name: Midodrine Hydrochloride Tablet
Manufacturer: Upsher-Smith Laboratories, LLC
Dosage Form: Tablet
Presentation: Orvaten, Tablet, 10 mg (NDC 0245-0213-11)
Package NDC: 0245-0213-11

Status & Timeline

Status: To Be Discontinued
First Reported: Apr 28, 2025
Last Updated: Apr 28, 2025
Therapeutic Category: Cardiovascular

Row fields from the FDA Drug Shortages database via openFDA.

Nearby, Other Midodrine Shortage Records

Midodrine Hydrochloride Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Midodrine Hydrochloride Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Midodrine Hydrochloride Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Midodrine Hydrochloride Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Midodrine Hydrochloride Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Midodrine Hydrochloride Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

← All Drug Shortages